Mark A Goldsmith - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Mark A Goldsmith

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Frontiers in Immunology|November 2, 2020

Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor ImmunityDarienne R Myers, Clare L Abram, David Wildes, et al.

The Journal of Experimental Medicine|March 20, 2002

Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1Oliver T Keppler, Frank J Welte, Tuan A Ngo, et al.

Nature Cell Biology|August 15, 2018

RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancersRobert J Nichols, Franziska Haderk, Carlos Stahlhut, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Frontiers in Immunology|November 2, 2020

Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor ImmunityDarienne R Myers, Clare L Abram, David Wildes, et al.

The Journal of Experimental Medicine|March 20, 2002

Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1Oliver T Keppler, Frank J Welte, Tuan A Ngo, et al.

Nature Cell Biology|August 15, 2018

RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancersRobert J Nichols, Franziska Haderk, Carlos Stahlhut, et al.

Pageof 3